Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Efficacy of novel mucosal vaccine delivery system described by RxKinetix in recent article

Jan. 18, 2002

Antex extends manufacturing agreement for vaccines

Jan. 17, 2002

Positive preliminary results from Corixa's phase III trial of RC-529 adjuvant

Jan. 15, 2002

Epimmune and Rhein Biotech enter research agreement for vaccine development

Jan. 11, 2002

Genencor and Johns Hopkins form strategic research collaboration

Jan. 9, 2002

IND submitted for AGI-1096 in prevention of organ transplant rejection

Jan. 8, 2002

Adjunctive therapy with Actimmune in a serious invasive fungal infection

Dec. 28, 2001

Cytovax files for approval to begin human trials of Cytovaxine

Dec. 27, 2001

BMS patents new series of IMPDH inhibitors

Dec. 24, 2001

Activax vaccine component enters clinical testing for prevention of travelers' diseases

Dec. 20, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....